A triple-blinded randomized trial comparing the hemostatic effects of large-dose 10% hydroxyethyl starch 264/0.45 versus 5% albumin during major reconstructive surgery

Anesthesia and Analgesia

Volumn 100, Issue 6, 2005, Pages 1846-1853

  Arellano, Ramiro ^a   Bing, Siang Gan ^b   Salpeter, Mary Jane ^b   Yeo, Erik ^b   McCluskey, Stuart ^b   Pinto, Ruxandra ^b   Irish, Jonathan ^b   Ross, Douglas C ^b   Doyle, D John ^b   Parkin, John ^b   Brown, Dale ^b   Rotstein, Lorne ^b   Witterick, Ian ^b   Matthews, Wayne ^b   Yoo, John ^b   Neligan, Peter C ^b   Gullane, Pat ^b   Lampe, Howard ^b  

^a KINGSTON GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BLOOD CLOTTING FACTOR 8; FENTANYL; HETASTARCH; ISOFLURANE; MORPHINE; NITROUS OXIDE PLUS OXYGEN; PANCURONIUM; SUXAMETHONIUM; THIOPENTAL; VON WILLEBRAND FACTOR;

ADULT; ANESTHESIA INDUCTION; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; FEMALE; HEAD AND NECK SURGERY; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EDEMA; LUNG EMBOLISM; MAJOR SURGERY; MALE; PARTIAL THROMBOPLASTIN TIME; PERIOPERATIVE PERIOD; PHARYNX CANCER; PLASTIC SURGERY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANESTHESIA; BLOOD COAGULATION; DOUBLE-BLIND METHOD; HEMODYNAMIC PROCESSES; HEMOSTATICS; HETASTARCH; INTERNATIONAL NORMALIZED RATIO; OROPHARYNGEAL NEOPLASMS; PARTIAL THROMBOPLASTIN TIME; RECONSTRUCTIVE SURGICAL PROCEDURES; SERUM ALBUMIN; VON WILLEBRAND FACTOR;

EID: 21044451108     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000152008.04333.53     Document Type: Article

References (28)

1. Boldt J. New light on intravascular volume replacement regimens: what did we learn from the past three years? Anesth Analg 2003;97:1595-604.
2. Martin G, Bennett-Guerrero E, Wakeling H, et al. A prospective, randomized comparison of thromboelastographic coagulation profile in patients receiving lactated Ringer's solution, 6% hetastarch in a balanced-saline vehicle, or 6% hetastarch in saline during major surgery. J Cardiothorac Vasc Anesth 2002;16:441-6.
3. Knutson JE, Deering JA, Hall FW, et al. Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery? Anesth Analg 2000;90:801-7.
4. Stump DC, Strauss RG, Henriksen RA, et al. Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. Transfusion 1985;25:349-54.
5. Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med 1999;25:258-68.
6. Franz A, Braunlich P, Gamsjager T, et al. The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 2001;92:1402-7.
7. Stogermuller B, Stark J, Willschke H, et al. The effect of hydroxyethyl starch 200 kD on platelet function. Anesth Analg 2000;91:823-7.
8. Strauss RG, Stump DC, Henriksen RA, Saunders R. Effects of hydroxyethyl starch on fibrinogen, fibrin clot formation, and fibrinolysis. Transfusion 1985;25:230-4.
9. Carr ME Jr. Effect of hydroxyethyl starch on the structure of thrombin- and reptilase-induced fibrin gels. J Lab Clin Med 1986;108:556-61.
10. Langeren O, Doelberg M, Ang ET, et al. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 2001;92:855-62.
11. Strauss RG, Stansfield C, Henriksen RA, Villhauer PJ. Pentastarch may cause fewer effects on coagulation than hetastarch. Transfusion 1988;28:257-60.
12. Strauss RG, Pennell BJ, Stump DC. A randomized, blinded trial comparing the hemostatic effects of pentastarch versus hetastarch. Transfusion 2002;42:27-36.
13. Vogt NH, Bothner U, Lerch G, et al. Large-dose administration of 6% hydroxyethyl starch 200/0.5 total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin. Anesth Analg 1996;83:262-8.
14. Sigurdsson GH. Perioperative fluid management in microvascular surgery. J Reconstr Microsurg 1995;11:57-65.
15. Huraux C, Ankri AA, Eyraud D, et al. Hemostatic changes in patients receiving hydroxyethyl starch: the influence of ABO blood group. Anesth Analg 2001;92:1396-401.
16. de Jonge E, Levi M, Buller HR, et al. Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects. Intensive Care Med 2001;27:1825-9.
17. Jamnicki M, Bombeli T, Seifert B, et al. Low- and medium-molecular-weight hydroxyethyl starches: comparison of their effect on blood coagulation. Anesthesiology 2000;93:1231-7.
18. Hobisch-Hagen P, Wirleitner B, Mair J, et al. Consequences of acute normovolaemic haemodilution on haemostasis during major orthopaedic surgery. Br J Anaesth 1999;82:503-9.
19. Khouri RK. Avoiding free flap failure. Clin Plast Surg 1992;19:773-81.
20. Haisch G, Boldt J, Krebs C, et al. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery. Anesth Analg 2001;92:565-71.
21. Mortier E, Ongenae M, De Baerdemaeker L, et al. In vitro evaluation of the effect of profound haemodilution with hydroxyethyl starch 6%, modified fluid gelatin 4% and dextran 40 10% on coagulation profile measured by thromboelastography. Anaesthesia 1997;52:1061-4.
22. Ruttmann TG, James MF, Aronson I. In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation. Br J Anaesth 1998;80:612-6.
23. Boldt J, Zickmann B, Herold C, et al. Influence of hypertonic volume replacement on the microcirculation in cardiac surgery. Br J Anaesth 1991;67:595-602.
24. Neff TA, Doelberg M, Jungheinrich C, et al. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg 2003;96:1453-9.
25. Cohen AJ, Kessler CM, Ewenstein BM. Management of von Willebrand disease: a survey on current clinical practice from the haemophilia centres of North America. Haemophilia 2001;7:235-41.
26. Conroy JM, Fishman RL, Reeves ST, et al. The effects of desmopressin and 6% hydroxyethyl starch on factor VIII:C. Anesth Analg 1996;83:804-7.
27. Kain K, Carter AM, Bamford JM, et al. Gender differences in coagulation and fibrinolysis in white subjects with acute ischemic stroke. J Thromb Haemost 2003;1:390-2.
28. Karkouti K, Cohen MM, McCluskey SA, Sher GD. A multivariable model for predicting the need for blood transfusion in patients undergoing first-time elective coronary bypass graft surgery. Transfusion 2001;41:1193-203.